Topical spironolactone, a skin-applied form of an androgen-blocking drug, has limited and partly indirect evidence for adult female acne in the 2026 review. Oral spironolactone has robust support for moderate-to-severe disease, while topical looks promising mainly for mild-to-moderate disease. Persistent acne here means facial acne lasting at least six months and judged severe enough to warrant oral antibiotics. Dove Medical Press reports the oral-versus-topical comparison in the 2026 narrative review, and adults with that pattern still need proven treatment rather than an unproven switch to a cream.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How do oral and topical compare?
- Why is topical evidence still weak?
- What supports oral treatment?
- What can adults with persistent acne discuss?
How do oral and topical compare?
Oral spironolactone is an effective non-antibiotic option for moderate-to-severe adult female acne. Topical spironolactone looks promising mainly for mild-to-moderate disease. The difference matters because severity guides treatment choice.
No trial directly compared topical spironolactone with oral spironolactone. That gap leaves doctors without head-to-head data on clearing, relapse, or long-term control. Patients should view topical use as experimental rather than equivalent.
Why is topical evidence still weak?
Topical studies were small, with none enrolling more than about 80 patients. They used short courses and varied 2-5% formulations. Many enrolled mixed-sex groups or healthy men and used nonstandard outcomes.
A 2025 systematic review and meta-analysis of 1,086 patients found 5% spironolactone reduced total lesions, severity, comedones, and papules after eight weeks. The PubMed record for that analysis reports excellent safety but reliance on few and single-arm studies in the 2025 meta-analysis. Small, uncontrolled designs cannot prove lasting benefit for persistent adult acne.
What supports oral treatment?
The strongest oral evidence comes from SAFA, a phase 3 double-blind trial with 410 adult women. The NIHR Journals Library describes randomization to spironolactone 50 mg daily rising to 100 mg versus placebo for 24 weeks in its Health Technology Assessment report on SAFA.
Participants were women aged 18 and older with persistent facial acne of at least six months. Their acne warranted oral antibiotics at entry. Spironolactone improved Acne-QoL symptom scores more than placebo at 12 and 24 weeks.
What can adults with persistent acne discuss?
Safety profiles differ by route. Topical use mainly caused mild local itching and burning. Very high laboratory concentrations degraded XPB protein involved in DNA repair, so the review stresses validated 2-5% concentrations.
For local androgen blockade without systemic effects, another option exists. Drugs.com notes that clascoterone 1% cream has FDA approval since 2020 for acne in people 12 and older, while neither oral nor topical spironolactone has FDA approval for acne in its comparison of Winlevi and spironolactone. Practical next steps include: Bring acne duration, severity, prior antibiotic use, and treatment goals to the visit.
- Confirm duration, severity, prior antibiotics, and hormonal patterns before changing treatment.
- Ask whether oral spironolactone fits moderate-to-severe persistent acne.
- Ask about approved local options when avoiding systemic effects matters.
- Avoid unvalidated compounded strengths outside 2-5% without clear oversight.
You Might Also Like
- Topical Hormonal Acne Treatments in a 2026 Review: What the Findings Mean for Adults With Persistent Acne
- Oral Doxycycline for Acne in a 2026 Systematic Review: What the Findings Mean for Adults With Persistent Acne
- Omega-3 Balance and Acne Questions in the 2026 Diet Review: Associations, Trials, and Evidence Gaps for Adults With Persistent Acne